メインコンテンツに移動
翻訳中 — お使いの言語版を準備している間、このコンテンツは英語で表示されています。

この記事を聴く:FDAのストレート・シューター:くだらないデータを銃撃戦に持ち込むな

Healthcare
United States
February 21, 2026に開始

Narrated Version | Inside Vinay Prasad's standoff with Moderna

Need to find a specific claim? Search all statements.
🗳️ Join the conversation
5 投票すべき主張 • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (7+ recommended) 5/7
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM 投稿者: will Feb 21, 2026
The FDA's demand for high-quality data is essential for ensuring public safety and trust in vaccines like Moderna's.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: will Feb 21, 2026
Vinay Prasad's criticism of Moderna highlights the dangers of prioritizing speed over scientific rigor in vaccine development.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: will Feb 21, 2026
While data quality is crucial, the FDA must balance urgency with thoroughness, especially in public health crises like the pandemic.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: will Feb 21, 2026
Critics argue that the FDA's stringent standards can delay access to potentially life-saving vaccines in desperate situations.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: will Feb 21, 2026
The debate over data quality versus urgency in vaccine approval reflects broader tensions in the healthcare system that need resolution.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results

💡 How This Works

  • Add Statements: Post claims or questions (10-500 characters)
  • Vote: Agree, Disagree, or Unsure on each statement
  • Respond: Add detailed pro/con responses with evidence
  • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us